Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
tolbutamid
|
first generation sulfonylurea
mech: close K+ channel in beta cell membrane so that cell depolarizes, releasing more insulin clincal use: useful in type 2 DM toxicity: disulfram-like effects |
|
chlorpropamide
|
first generation sulfonylurea
mech: close K+ channel in beta cell membrane so that cell depolarizes, releasing more insulin clincal use: useful in type 2 DM toxicity: disulfram-like effects |
|
glyburide
|
2nd generation sulfonylurea
mech: close K+ channels, beta cells depolarize, releasing more insulin use: type 2 DM side effects: hypoglycemia |
|
glimepiride
|
2nd generation sulfonylurea
mech: close K+ channels, beta cells depolarize, releasing more insulin use: type 2 DM side effects: hypoglycemia |
|
glipizide
|
2nd generation sulfonylurea
mech: close K+ channels, beta cells depolarize, releasing more insulin use: type 2 DM side effects: hypoglycemia |
|
metformin
|
biguanide
exact mechanism unkown - decrease glconeogenesis, increase glycolysis, lower glucose levels (insulin sensitizer) use - type 2 DM toxicity: lactic acidosis |
|
glitazones
|
rosiglitazone, pioglitazone
mech: increase target cell response to insulin by regulating adipokines use: monotherapy or combined for type 2 DM toxicity: wieght gain, edema, hepato and cardio toxic perhaps |
|
acarbose
|
alpha-glucosidase inhibitor
mechanism - delayed sugar hydrolysis/glucose absorption at brush border use: T2DM side effects: GI |
|
miglitol
|
alpha-glucosidase inhibitor
delays sugar hydrolysis and glucose uptake at brush border Use: type 2 DM side effects: GI |
|
pramlintide
|
mimics amylin, which lower glucagon and sensities insulin effects
use: t2dm, type 1 also? side effects: hypoglycemia, nausea, diarrhea |
|
exenatide
|
raises insulin, lowers glucagon release
use: type 2 side effects: N/V, maybe pancreatitis |
|
orlistat
|
inhibits pancreatic lipase
use: obesity side effects: steatorhaa, GI discomfort, reduced absorption of ADEK |
|
sibutramine
|
mechanism: sympathomimetic serotonin, NE reuptake inhibitor
use: obesity toxicity: htn, tachycardia |
|
propylthiouraicl, methimazole
|
mechanism: inhibit thyroid hormone synthesis, decreased peripheral conversion T4 to T3 (propylthiouracil)
use: hyperthyroid toxicity: rare agranulocytosis, aplastic anemia. rash. |
|
GH
|
GH deficiency, turners
|
|
somatostatin (octreotide)
|
acromegaly, carcinoid syndrome, gastrinoma, glucagonoma
inhibits GH, TSH and all the gastropeptides (VIP, gastrin etc) |
|
oxytocin
|
stimulates labor and ocntraction, milk let-down
controls uterine hemorrhage |
|
ADH (desmopressin)
|
central DI
|
|
levothyroxine
|
hypothyroid, myxedema
toxicity: tachycardia, heat intolerance, tremors, arrhythima |
|
demeclocycline
|
ADH antagonist
used for SIADH toxicity: photosensitivity; abnormalities of bone and teeth |